Phytochemical Fingerprinting and Therapeutic Efficacy of Blumea lacera (Burm.f.) DC.: Mechanistic Insights into its Anti-inflammatory and Hepatoprotective Potential
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (48s)
DOI: 10.25258/ijddt.16.48s.94 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Vijayendra Kumar Pandey und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Blumea lacera (Burm.f.) DC. (Kukkuradru) is an important medicinal plant in Ayurvedic medicine traditionally used for the management of inflammatory and hepatic disorders. Despite its ethnomedicinal relevance, the plant remains insufficiently characterized due to limited validated pharmacopoeial standards and inadequate quantitative chromatographic data linking its pharmacological activity with specific phytochemical markers. The present study aimed to address this gap through targeted phytochemical fingerprinting and evaluation of its anti-inflammatory and hepatoprotective activities. The aerial parts of B. lacera were subjected to polarity-guided successive extraction. The methanolic extract was standardized using High-Performance Liquid Chromatography (HPLC) for flavone quantification. In vivo pharmacological activity was evaluated using carrageenan-induced paw edema and paracetamol-induced hepatotoxicity models in Wistar rats following acute oral toxicity assessment according to OECD guideline 423. HPTLC analysis established a reproducible chromatographic fingerprint and quantified betasitosterol (8.4 mg/g) and stigmasterol (5.1 mg/g) in the methanolic extract. HPLC analysis confirmed the presence of luteolin (3.82 mg/g) and apigenin (2.15 mg/g). The extract demonstrated a high safety margin with an LD50 value greater than 2000 mg/kg. Treatment with the extract at 500 mg/kg produced significant inhibition of carrageenaninduced paw edema, showing 37.71% inhibition during the late inflammatory phase. In the hepatoprotective model, the extract significantly reduced elevated serum ALT, AST, and ALP levels and restored total protein levels compared with the toxic control group. Histopathological examination further confirmed hepatoprotective activity through reduction of centrilobular necrosis and preservation of hepatic architecture. The findings provide scientific evidence supporting the anti-inflammatory and hepatoprotective potential of B. lacera. The observed pharmacological activities may be associated with the combined effects of phytosterols and flavonoids present in the extract. The study supports the traditional medicinal use of the plant and establishes a phytochemical and pharmacological basis for future development of standardized herbal formulations.
Zitieren
APA
Pandey, V. K., & Jain, G. (2026). Phytochemical Fingerprinting and Therapeutic Efficacy of Blumea lacera (Burm.f.) DC.: Mechanistic Insights into its Anti-inflammatory and Hepatoprotective Potential. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.94
Vancouver
Pandey VK, Jain G. Phytochemical Fingerprinting and Therapeutic Efficacy of Blumea lacera (Burm.f.) DC.: Mechanistic Insights into its Anti-inflammatory and Hepatoprotective Potential. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.94
BibTeX
@article{Pandey2026,
author = {Pandey, Vijayendra Kumar and Jain, Gaurav},
title = {Phytochemical Fingerprinting and Therapeutic Efficacy of Blumea lacera (Burm.f.) DC.: Mechanistic Insights into its Anti-inflammatory and Hepatoprotective Potential},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {48s},
doi = {10.25258/ijddt.16.48s.94}
}
EUVIMED